EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Neuropathogenesis of Old World Alphaviruses: Considerations for the Development of Medical Countermeasures

Alyssa M Lantz iD, Victoria K Baxter iD

Viruses · 14.02.2025 · 17 (2) · 261

DOI: 10.3390/v17020261 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 14.02.2025. Verfasst von Alyssa M Lantz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Texas Biomedical Research Institute, San Antonio, TX 78227, USA. Hauptthemen laut MEDLINE: Alphavirus, Alphavirus Infections, Nervous System Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chikungunya virus (CHIKV) and other alphaviruses that primarily induce arthritogenic disease in humans, known as “Old World” alphaviruses, present an emerging public health concern as geographic ranges of mosquito vectors expand due to climate change. While a vaccine against CHIKV has recently been approved by several countries in North America and Europe, access to effective preventative countermeasures against disease induced by Old World alphaviruses remains elusive for the most vulnerable populations. Furthermore, treatment options continue to be limited to supportive care. Atypical neurological disease manifestations caused by Old World alphaviruses, which make up as many as 25% of the cases in some CHIKV outbreaks, present special challenges when considering strategies for developing effective countermeasures. This review focuses on Old World alphaviruses, specifically CHIKV, Ross River virus, O’nyoug-nyoug virus, and Mayaro virus, concentrating on the atypical neurological disease manifestations they may cause. Our current understanding of Old World alphavirus neuropathogenesis, gained from human cases and preclinical animal models, is discussed, including viral and host factors’ roles in disease development. The current state of alphavirus preventatives and treatments, both virus-targeting and host-directed therapies, is then summarized and discussed in the context of addressing neurological disease induced by Old World alphaviruses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlphavirusAlphavirus InfectionsNervous System DiseasesHumansAnimalsDisease Models, Animal

Stichwörter der Autor:innen

Old World alphaviruseschikungunya virusneurological diseaseneuropathogenesistreatmentsvaccines

Autor:innen und Institutionen

  • Texas Biomedical Research Institute, San Antonio, TX 78227, USA.

ORCID-Profile: Alyssa M Lantz, Victoria K Baxter

Förderung

  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Lantz, A. M., & Baxter, V. K. (2025). Neuropathogenesis of Old World Alphaviruses: Considerations for the Development of Medical Countermeasures. Viruses, 17(2), 261. https://doi.org/10.3390/v17020261

Vancouver

Lantz AM, Baxter VK. Neuropathogenesis of Old World Alphaviruses: Considerations for the Development of Medical Countermeasures. Viruses. 2025;17(2):261. doi:10.3390/v17020261

BibTeX
@article{Lantz2025,
  author = {Lantz, Alyssa M and Baxter, Victoria K},
  title = {Neuropathogenesis of Old World Alphaviruses: Considerations for the Development of Medical Countermeasures},
  journal = {Viruses},
  year = {2025},
  volume = {17},
  number = {2},
  pages = {261},
  doi = {10.3390/v17020261}
}
Kostenlos starten →